Mutiah, Roihatul, Firdausy, Alif Firman, Dewi, Tanaya Jati Dharma and Rahmawati, Eka Kartini (2021) In silico prediction of the antiangiogenesis activity of Heliannuol lactone sesquiterpenes compounds from Sunflower (Heliannthus annuus L.). Indonesian Journal of Cancer Chemoprevention, 12 (2). pp. 90-98. ISSN 2355-8989
|
Text
9479.pdf - Published Version Available under License Creative Commons Attribution Non-commercial. Download (1MB) | Preview |
Abstract
Heliannuols are sesquiterpenes lactone compounds considered to have anticancer activity on the brain cancer. Cancer cell growth is related to overexpression of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) as a pro-angiogenic pathway, which becomes the main factor of angiogenesis and progression. This research aims to predict anti-angiogenic, toxicity, and physicochemical properties of heliannuols. Physicochemical properties were predicted referred to Lipinski’s rule of five (Lipinski RO5), while absorption, distribution, metabolism, and excretion were predicted by using pkCSM online tool. The toxicity of compounds was predicted by using Protox II online tool, and interaction of the ligand with receptors was predicted by conducting validation (VEGFR-2 (PDB ID: 3WZE)) and molecular docking using Molegro Virtual Docker (MVD). The result revealed that Lipinski RO5 compatible heliannuols had the lowest LD50 2148 mg/kg predictive LD50 predictive values of heliannuol D. The docking result was described by rerank score (RS), representing the bound energy form and compares with Sorafenib as a reference drug. Five medium strength VEGFR-2 chemical substances with rerank score: heliannuol A -56.9496, heliannuol heliannuol B -70.83646, heliannuol C -61,3292, heliannuol D -49.61646, and heliannuol E -75.5164. No better rerank score was recorded for all inhibitors than sorafenib (-128.0683). The heliannuols interacted with amino acid residues Glu885 and Asp1046 that probably conferred the antiangiogenic activity. Taken together, heliannuol D had the greates activity to the target protein and complied Lipinski RO5.
Item Type: | Journal Article |
---|---|
Keywords: | anti-angiogenic; toxicity; heliannuol; VEGFR-2; brain cancer; molecular docking |
Subjects: | 11 MEDICAL AND HEALTH SCIENCES > 1112 Oncology and Carcinogenesis > 111201 Cancer Cell Biology |
Divisions: | Faculty of Medical and Health Sciences > Department of Pharmacy |
Depositing User: | Dr. M.Kes. Roihatul Muti'ah |
Date Deposited: | 29 Oct 2021 13:59 |
Downloads
Downloads per month over past year
Origin of downloads
Actions (login required)
View Item |